22:39:30 EST Wed 22 Nov 2017
Enter Symbol
or Name
USA
CA



Veritas Pharma Inc
Symbol C : VRT
Shares Issued 21,200,000
Close 2017-04-20 C$ 0.46
Recent Sedar Documents

Veritas Pharma pays final instalment for Cannevert

2017-04-21 07:15 ET - News Release

Dr. Lui Franciosi reports

VERITAS PHARMA INC CLOSES ON ITS ACQUISITION OF CANNEVERT THERAPEUTICS LTD

Veritas Pharma Inc., further to its Dec. 21, 2015, and Oct. 5, 2016, news releases, has paid the final instalment for its acquisition of 80 per cent of the issued and outstanding shares in Cannevert Therapeutics Ltd., and the company will enter into a second amending agreement with respect to the existing share purchase agreement with Cannevert.

Pursuant to the second amending agreement, the company and Cannevert will engage an independent business valuator within 90 days to report on the value of Cannevert. The company will provide a future update once a valuator has been appointed.

About Veritas Pharma Inc.

Veritas Pharma is an emerging-stage pharmaceutical and intellectual property development company, which, through Cannevert Therapeutics Ltd., is advancing the science behind medical cannabis.

We seek Safe Harbor.

© 2017 Canjex Publishing Ltd. All rights reserved.